Report overview
The global Interventional Devices for Structural Heart Disease market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Interventional Devices for Valvular Disease Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Interventional Devices for Structural Heart Disease include Edwards Lifesciences, Boston Scientific Corporation, Medtronic, Abbott, Livanova, Cryolife, Braile Biomedica, Biomerics, LLC and NuMed Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Structural heart disease refers to physical and physiological changes in the heart caused by abnormalities in heart tissue or valves. Many structural heart diseases are congenital, and some structural heart disease develops later in life. There are three types of treatment for structural heart disease: drug therapy, transcatheter intervention, and open-heart surgery. Structural heart disease interventional devices are used in interventional therapy. Common interventional devices include congenital heart disease occluders, cardiogenic stroke occluders and heart valve products.
This report aims to provide a comprehensive presentation of the global market for Interventional Devices for Structural Heart Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Devices for Structural Heart Disease. This report contains market size and forecasts of Interventional Devices for Structural Heart Disease in global, including the following market information:
Global Interventional Devices for Structural Heart Disease Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Interventional Devices for Structural Heart Disease Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Interventional Devices for Structural Heart Disease companies in 2023 (%)
We surveyed the Interventional Devices for Structural Heart Disease manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interventional Devices for Structural Heart Disease Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Interventional Devices for Structural Heart Disease Market Segment Percentages, by Type, 2023 (%)
Interventional Devices for Valvular Disease
Interventional Devices for Cardiogenic Stroke
Interventional Devices for Congenital Heart Disease
Global Interventional Devices for Structural Heart Disease Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Interventional Devices for Structural Heart Disease Market Segment Percentages, by Application, 2023 (%)
Congenital Heart Disease
Acquired Heart Disease
Global Interventional Devices for Structural Heart Disease Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Interventional Devices for Structural Heart Disease Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Interventional Devices for Structural Heart Disease revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Interventional Devices for Structural Heart Disease revenues share in global market, 2023 (%)
Key companies Interventional Devices for Structural Heart Disease sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Interventional Devices for Structural Heart Disease sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Edwards Lifesciences
Boston Scientific Corporation
Medtronic
Abbott
Livanova
Cryolife
Braile Biomedica
Biomerics, LLC
NuMed Inc.
AtriCure, Inc.
Comed B.V.
Shenzhen Salubris Pharmaceuticals Co., Ltd
LifeTech Scientific Corporation
Shanghai Push Medical Device Technology Co.,LTD
MicroPort Scientific Corporation
Scientech Medical
Starway Medical Technology Inc
Venus Medtech (Hangzhou) Inc.
APT Medical Inc
Shanghai HeartCare Medical Technology Co., Ltd
Peijia Medical Limited
Shanghai Hanyu Medical Technology Co., Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Interventional Devices for Structural Heart Disease, market overview.
Chapter 2: Global Interventional Devices for Structural Heart Disease market size in revenue and volume.
Chapter 3: Detailed analysis of Interventional Devices for Structural Heart Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Interventional Devices for Structural Heart Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Interventional Devices for Structural Heart Disease capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
